Cargando…

Myocardial performance index: Is it time to revisit this old parameter in COVID-19 patients?

Detalles Bibliográficos
Autor principal:	Timóteo, Ana Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. 2022
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853747/ https://www.ncbi.nlm.nih.gov/pubmed/35194314 http://dx.doi.org/10.1016/j.repc.2022.02.005

Ejemplares similares

Myocardial infarction in the COVID-19 pandemic – Reperfusion therapy revisited
por: Ferreira, Jorge
Publicado: (2021)

Myocardial infarction in the COVID-19 pandemic – Reperfusion therapy revisited
por: Ferreira, Jorge
Publicado: (2021)

Revisiting the initial COVID-19 pandemic projections
por: Biggs, Adam T, et al.
Publicado: (2021)

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
por: Malek, Alexandre E.
Publicado: (2021)

COVID-19 Revisited, Biomarkers in Myocardial Infarction
Publicado: (2023)

Myocardial infarction, atrial fibrillation and mortality: timing is everything
por: van den Berg, N.W.E., et al.
Publicado: (2015)

Real-time COVID-19 forecasting: challenges and opportunities of model performance and translation
por: Nixon, Kristen, et al.
Publicado: (2022)

Correlation between body mass index and COVID-19 transmission risk
por: de la Rosa-Zamboni, Daniela, et al.
Publicado: (2022)

ST-elevation myocardial infarction in the Covid-19 pandemic: A step backward in a success story
por: Carvalho, Henrique Cyrne
Publicado: (2022)

RNA-editing in Basidiomycota, revisited
por: Min, Byoungnam, et al.
Publicado: (2021)

Can left ventricular function parameters be determined within half of the time with MRI?
por: Baur, Leo H. B.
Publicado: (2007)

Impact of COVID-19 on mortality under 5 years old
por: Takefuji, Yoshiyasu
Publicado: (2023)

Is It Time to Revisit Remdesivir Use for Severe COVID-19?
por: Taggarsi, Dipali Anand
Publicado: (2022)

Triage in the time of COVID-19
por: Gilbert, Allison, et al.
Publicado: (2022)

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
por: Björkqvist, Maria
Publicado: (2023)

What is the best myocardial perfusion protocol in diabetic patients?
por: Baur, Leo H. B.
Publicado: (2007)

Improving Left Ventricular Myocardial Function After Myocardial Infarction: Is it in the BAG?
por: McTiernan, Charles F.
Publicado: (2016)

Revisiting the role of acute kidney injury in patients on immune checkpoint inhibitors: a good prognosis renal event with a significant impact on survival
por: García-Carro, Clara, et al.
Publicado: (2023)

Preliminary results of a clinical study to evaluate the performance and safety of swallowing in critical patients with COVID-19
por: de Lima, Maíra Santilli, et al.
Publicado: (2020)

No time for complacency on COVID-19 in Europe
por: Flahault, Antoine, et al.
Publicado: (2023)

The Incremental Effect of Obesity on Myocardial Fibrosis In Patients with Aortic Stenosis
por: Yoon, Se-Jung
Publicado: (2016)

Elucidating the effect of geriatric parameters on COVID-19 outcomes for older adults with cancer
por: Milton, Martine, et al.
Publicado: (2022)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

New insights into the association between body-mass index and severe COVID-19
por: Bhaskaran, Krishnan
Publicado: (2021)

Assessing national performance in response to COVID-19
por: Fisher, Dale, et al.
Publicado: (2020)

Acute myocardial infarction in the elderly
por: Zijlstra, F., et al.
Publicado: (2015)

Index of Volume One
Publicado: (1918)

The time to do serosurveys for COVID-19 is now
por: Peeling, Rosanna W, et al.
Publicado: (2020)

Offline: Health in the unhappy time of COVID-19
por: Horton, Richard
Publicado: (2020)

Intestinal helminths – An old foe revisited
por: Parija, Subhash Chandra
Publicado: (2017)

Does rural primary care ophthalmology teaching need revisiting?
por: Patel, Chirag
Publicado: (2020)

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
por: Boekel, L, et al.
Publicado: (2022)

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19
por: Shapiro, Adrienne E, et al.
Publicado: (2022)

The Social, Economic and Sanitary Impact of COVID-19 Pandemic
por: Gómez, Ana María Autrán, et al.
Publicado: (2020)

Awake prone positioning in COVID-19: is tummy time ready for prime time?
por: Weatherald, Jason, et al.
Publicado: (2021)

Time to press the reset button—can we use the COVID-19 pandemic to rethink the process of transplant assessment?
por: Kumar, Mukesh, et al.
Publicado: (2021)

COVID-19, sports, and myocardial consequences
por: Jørstad, H. T., et al.
Publicado: (2020)

Metabolic Syndrome and Myocardial Contractile Reserve
por: Kim, Seong Hwan
Publicado: (2011)

Costs and benefits of treatment of myocardial infarction
por: Simoons, M. L.
Publicado: (2013)

Editorial Comment to Cystic partially differentiated nephroblastoma in a 74‐year‐old patient
por: Yuasa, Takeshi
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqlk82uv849taocsh04v6bhtsv